CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
-2.22%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+0.55%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
509
New
13
Increased
172
Reduced
270
Closed
23
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Amazon
AMZN
|
$8.41M |
| 3 |
Microsoft
MSFT
|
$6.53M |
| 4 |
Analog Devices
ADI
|
$4.63M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$3.68M |
Top Sells
| 1 |
iShares Silver Trust
SLV
|
$7.9M |
| 2 |
ProShares Ultra Gold
UGL
|
$7.89M |
| 3 |
Arista Networks
ANET
|
$6.7M |
| 4 |
Gilead Sciences
GILD
|
$5.26M |
| 5 |
TSMC
TSM
|
$3.61M |
Sector Composition
| 1 | Technology | 36.93% |
| 2 | Healthcare | 24.36% |
| 3 | Consumer Discretionary | 11.82% |
| 4 | Communication Services | 11.17% |
| 5 | Consumer Staples | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Verizon
VZ
$184B
| $1.06M | 0.1% |
23,397
+2,555
| +12% | +$116K |
|
177
Thermo Fisher Scientific
TMO
$183B
| $1.06M | 0.1% |
2,126
+235
| +12% | +$117K |
|
178
Guardant Health
GH
$8.11B
| $1.05M | 0.1% |
24,756
-1,442
| -6% | -$61.4K |
|
179
McKesson
MCK
$85.9B
| $1.04M | 0.1% |
+1,548
| New | +$1.04M |
|
180
Krystal Biotech
KRYS
$4.35B
| $1.04M | 0.1% |
5,778
-320
| -5% | -$57.7K |
|
181
Ross Stores
ROST
$49.3B
| $1.04M | 0.1% |
8,149
+2,750
| +51% | +$351K |
|
182
Verisk Analytics
VRSK
$37.5B
| $1.03M | 0.1% |
3,465
+1,167
| +51% | +$347K |
|
183
Xcel Energy
XEL
$42.8B
| $1.01M | 0.09% |
14,191
+4,846
| +52% | +$345K |
|
184
Axon Enterprise
AXON
$56.9B
| $996K | 0.09% |
1,893
+652
| +53% | +$343K |
|
185
Walt Disney
DIS
$211B
| $993K | 0.09% |
10,065
+9,621
| +2,167% | +$950K |
|
186
VF Corp
VFC
$5.79B
| $992K | 0.09% |
63,906
+4,326
| +7% | +$67.1K |
|
187
Coca-Cola Europacific Partners
CCEP
$39.4B
| $991K | 0.09% |
11,385
+3,893
| +52% | +$339K |
|
188
Tenet Healthcare
THC
$16.5B
| $986K | 0.09% |
7,331
+4,081
| +126% | +$549K |
|
189
Vaxcyte
PCVX
$4.17B
| $975K | 0.09% |
25,827
-601
| -2% | -$22.7K |
|
190
Ionis Pharmaceuticals
IONS
$9.64B
| $962K | 0.09% |
31,886
-1,594
| -5% | -$48.1K |
|
191
Cytokinetics
CYTK
$5.98B
| $955K | 0.09% |
23,751
-1,272
| -5% | -$51.1K |
|
192
Goldman Sachs
GS
$221B
| $953K | 0.09% |
1,745
+181
| +12% | +$98.9K |
|
193
Nuvalent
NUVL
$5.74B
| $941K | 0.09% |
13,271
-642
| -5% | -$45.5K |
|
194
ADMA Biologics
ADMA
$4.03B
| $941K | 0.09% |
47,416
-2,707
| -5% | -$53.7K |
|
195
Cognizant
CTSH
$35.1B
| $935K | 0.09% |
12,217
+4,148
| +51% | +$317K |
|
|
HSAI
196
Hesai Group
HSAI
$3.43B
| $932K | 0.09% |
63,000
+19,000
| +43% | +$281K |
|
197
Electronic Arts
EA
$42B
| $930K | 0.09% |
6,437
+2,169
| +51% | +$313K |
|
198
GE HealthCare
GEHC
$33B
| $912K | 0.08% |
11,295
+3,860
| +52% | +$312K |
|
199
Protagonist Therapeutics
PTGX
$3.62B
| $908K | 0.08% |
18,772
+6,135
| +49% | +$297K |
|
200
Genmab
GMAB
$16.7B
| $905K | 0.08% |
46,202
+37,311
| +420% | +$731K |
|